DaVita Inc. (NYSE:DVA) Shares Sold by Tobam

Tobam lowered its holdings in shares of DaVita Inc. (NYSE:DVA) by 70.4% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 4,475 shares of the company’s stock after selling 10,654 shares during the period. Tobam’s holdings in DaVita were worth $685,000 as of its most recent SEC filing.

A number of other large investors have also recently bought and sold shares of DVA. UMB Bank n.a. lifted its stake in shares of DaVita by 65.5% in the first quarter. UMB Bank n.a. now owns 192 shares of the company’s stock valued at $29,000 after purchasing an additional 76 shares during the period. Copia Wealth Management acquired a new stake in shares of DaVita in the fourth quarter valued at about $30,000. SBI Securities Co. Ltd. acquired a new stake in shares of DaVita in the fourth quarter valued at about $41,000. Coppell Advisory Solutions LLC increased its holdings in DaVita by 50.0% during the 4th quarter. Coppell Advisory Solutions LLC now owns 300 shares of the company’s stock valued at $45,000 after acquiring an additional 100 shares in the last quarter. Finally, Canada Post Corp Registered Pension Plan purchased a new position in DaVita during the 4th quarter valued at about $55,000. Institutional investors and hedge funds own 90.12% of the company’s stock.

Analysts Set New Price Targets

DVA has been the subject of several recent research reports. Sanford C. Bernstein set a $184.00 target price on shares of DaVita in a report on Friday, February 21st. Wall Street Zen upgraded shares of DaVita from a “hold” rating to a “buy” rating in a report on Friday, April 25th. Barclays lifted their price target on shares of DaVita from $164.00 to $169.00 and gave the stock an “equal weight” rating in a report on Tuesday, February 18th. Truist Financial lowered their price target on shares of DaVita from $170.00 to $164.00 and set a “hold” rating for the company in a report on Monday, May 19th. Finally, Cowen reiterated a “hold” rating on shares of DaVita in a report on Tuesday, February 18th. One analyst has rated the stock with a sell rating, four have given a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $164.50.

DaVita Stock Down 0.8%

DaVita stock opened at $137.11 on Friday. The company has a 50-day simple moving average of $141.52 and a 200-day simple moving average of $151.40. The firm has a market capitalization of $10.35 billion, a P/E ratio of 12.77, a P/E/G ratio of 1.07 and a beta of 1.11. The company has a debt-to-equity ratio of 23.18, a quick ratio of 1.21 and a current ratio of 1.26. DaVita Inc. has a one year low of $131.76 and a one year high of $179.60.

DaVita (NYSE:DVA) last issued its quarterly earnings results on Monday, May 12th. The company reported $2.00 earnings per share for the quarter, beating analysts’ consensus estimates of $1.75 by $0.25. DaVita had a net margin of 7.31% and a return on equity of 115.48%. The company had revenue of $3.22 billion during the quarter, compared to the consensus estimate of $3.22 billion. During the same period in the prior year, the company earned $2.26 EPS. DaVita’s revenue was up 5.0% on a year-over-year basis. As a group, equities analysts expect that DaVita Inc. will post 10.76 earnings per share for the current year.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.